BioSpace News Archive

The demand within the global market for vaccines has been rising on account of advancements in the field of medical therapy and disease prevention, finds Transparency Market Research.

Convalescent plasma therapy, more popularly plasma therapy, is gained groundswell of attention in the healthcare industry for its potential in treating COVID-19 cases, propelling the expansion in the plasma therapy market.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company, is pleased to announce that it has now enrolled 75% of its enrollment target, which is 113 patients, for its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19. The multinational human trial is being conducted in the U.S., Australia,

What’s New: Today, Intel Federal LLC announced a three-year agreement with Sandia National Laboratories (Sandia) to explore the value of neuromorphic computing for scaled-up computational problems

Today, Blue Wolf Capital Partners (“Blue Wolf”), a New York-based private equity firm, announced the completion of the sale of Pharmaceutical

Today, the Lupus Foundation of America (LFA) and the American Academy of Family Physicians (AAFP) announced a collaboration to ensure family physicians, who can play an important role in the lupus diagnosis process, have the tools and resources to recognize the signs and symptoms of lupus and help people with lupus better manage the

Benuvia Manufacturing, LLC, a customer focused contract development and manufacturing organization (CDMO) and leading developer of active pharmaceutical ingredients and drug products, announced the appoin